Physiology of Wound Healing

Introduction to Wound Healing Biology

Wound healing is a complex, coordinated biological process involving multiple cell types, signaling molecules, and extracellular matrix components. This intricate cascade of events transforms damaged tissue into functional repair tissue through carefully orchestrated phases. Understanding these mechanisms is crucial for healthcare professionals to optimize healing outcomes, prevent complications, and recognize when interventions are necessary to support the natural repair process.

Key Cellular Players in Tissue Repair

The cellular players in wound repair include platelets for hemostasis and growth factor release, neutrophils for bacterial clearance, macrophages for debris removal and tissue coordination, fibroblasts for collagen synthesis, endothelial cells for angiogenesis, and keratinocytes for re-epithelialization. Each cell type has specific functions and timing within the healing cascade, and dysfunction in any cellular component can lead to impaired healing or chronic wound formation.

Normal vs. Abnormal Healing Patterns

Normal wound healing progresses through predictable phases with characteristic timeframes and cellular activities. Acute wounds typically heal within 4-6 weeks following an orderly sequence of hemostasis, inflammation, proliferation, and remodeling. In contrast, chronic wounds exhibit prolonged inflammation, impaired cellular function, elevated protease activity, and growth factor degradation. Recognizing these patterns allows clinicians to identify healing complications early and implement appropriate interventions.

Clinical Significance and Assessment

Clinical assessment of wound healing involves monitoring phase progression, cellular activity markers, and molecular environment changes. Key indicators include appropriate inflammatory response duration, granulation tissue formation, epithelialization rate, and tissue maturation quality. Understanding the physiological basis of these processes enables healthcare providers to make evidence-based decisions about wound management strategies and predict healing challenges before they become problematic.

Hemostasis (0-24 hours)

The first phase involves platelet aggregation and plug formation, coagulation cascade activation, and fibrin clot stabilization. Key molecular players include platelets, fibrinogen, thrombin, and Factor XIII. This phase lays the foundation for all subsequent healing phases.

Inflammatory Phase (1-5 days)

Critical for debridement and growth factor release, this phase features neutrophil recruitment and activation, macrophage differentiation from the M1 (pro-inflammatory) to M2 (tissue repair) phenotype, and cytokine cascade regulation. Key mediators include TNF-α, IL-1β, IL-6, PDGF, and TGF-β.

Proliferative Phase (5-21 days)

The tissue building and wound closure phase involves fibroblast migration and collagen synthesis, angiogenesis and capillary sprouting, and keratinocyte migration and re-epithelialization. Key molecular players include VEGF, FGF-2, Type III Collagen, and Fibronectin.

Remodeling Phase (21 days - 2 years)

The final phase determines the strength and appearance of healed tissue. It involves collagen crosslinking and reorganization, the transition from Type III to Type I collagen, and tensile strength development through the action of collagenase, Type I Collagen, and lysyl oxidase.

Platelets

Active during hemostasis and early inflammation, platelets release key molecules including PDGF, TGF-β, EGF, and Serotonin. Their primary functions are hemostasis, growth factor release, and inflammatory cell recruitment.

Neutrophils

The first immune responders during the inflammatory phase (24-72 hours), neutrophils utilize elastase, myeloperoxidase, and IL-8 receptors for bacterial clearance, debris removal, and reactive oxygen species generation.

Macrophages

Present throughout all phases with phenotype switching, macrophages exist as M1 (pro-inflammatory) and M2 (tissue repair) subtypes. They use TNF-α, VEGF, MMPs, and arginase for phagocytosis, growth factor secretion, and tissue remodeling coordination. Macrophages are considered the master regulators of wound healing.

Fibroblasts

Active during proliferative and remodeling phases, fibroblasts produce Collagen I/III, Fibronectin, α-SMA, and HGF. They are responsible for extracellular matrix synthesis, contractile force generation, and growth factor production.

Endothelial Cells

Critical during proliferative phase angiogenesis, endothelial cells express VEGF receptors, angiopoietins, eNOS, and VWF to drive angiogenesis, regulate vascular permeability, and maintain hemostasis.

Keratinocytes

During proliferative phase migration and proliferation, keratinocytes use EGF receptors, integrins, MMPs, and defensins for re-epithelialization, barrier restoration, and antimicrobial peptide production.

PDGF Family

The PDGF family (PDGF-AA, BB, CC, DD) acts through PDGFR-α and PDGFR-β receptors via PI3K/Akt, MAPK/ERK, and PLCγ signaling pathways. Primary functions include fibroblast chemotaxis, angiogenesis, and smooth muscle cell proliferation.

TGF-β Superfamily

Comprising TGF-β1, β2, β3, BMP-2, and BMP-7, this family signals through TβRI, TβRII, and BMPR receptors via Smad2/3, Smad1/5/8, and non-Smad pathways. It drives ECM synthesis, inflammation resolution, and epithelial-mesenchymal transition.

VEGF Family

VEGF-A, B, C, D and PlGF act through VEGFR-1, VEGFR-2, VEGFR-3, and Neuropilins. Signaling via PI3K/Akt, MAPK, and PLCγ/PKC pathways drives angiogenesis, vascular permeability regulation, and lymphangiogenesis.

FGF Family

FGF-1, FGF-2, FGF-7, and FGF-10 signal through FGFR1-4 via MAPK/ERK, PI3K/Akt, and PLCγ pathways to drive cell proliferation, angiogenesis, and re-epithelialization.

Pathway Crosstalk

These signaling networks do not operate in isolation. TGF-β and PDGF work synergistically in fibroblast activation, VEGF and FGF cooperate in angiogenesis, and inflammatory cytokines modulate growth factor responses throughout the healing process.

Age-Related Changes

Aging results in decreased collagen synthesis and increased degradation, reduced growth factor responsiveness, impaired angiogenic response, and delayed inflammatory resolution. The molecular basis involves cellular senescence, telomere shortening, and oxidative stress accumulation.

Metabolic Disorders: Diabetes Mellitus

Diabetes impairs wound healing through advanced glycation end products (AGEs) cross-linking, impaired neutrophil function and bacterial clearance, reduced growth factor activity, and microvascular dysfunction. The molecular basis involves protein kinase C activation, polyol pathway flux, and oxidative stress.

Nutritional Status

Critical nutrients for wound healing include protein (collagen synthesis), Vitamin C (collagen hydroxylation), zinc (metalloproteinase cofactor), and Vitamin A (epithelialization). Nutritional deficiency is one of the most common modifiable factors in impaired wound healing.

Mechanical Environment

Pressure, shear forces, moisture balance, and temperature all affect healing. Optimal conditions include a moist, warm, protected environment with appropriate tension. Excessive mechanical stress delays healing and can convert acute wounds to chronic ones.

Infection and Biofilms

Infection prolongs the inflammatory phase, increases protease activity, degrades growth factors, and causes tissue hypoxia. Biofilms represent a particular challenge as they resist standard antimicrobial treatments and maintain chronic inflammation.

Medications

Corticosteroids, NSAIDs, chemotherapy agents, and anticoagulants can negatively impact healing. Conversely, growth factors, hyperbaric oxygen, and negative pressure therapy can positively influence wound repair outcomes.

Chronic Wound Characteristics

Chronic wounds are characterized by senescent fibroblasts with reduced synthetic capacity, a persistent M1 macrophage phenotype, impaired keratinocyte migration, and endothelial cell dysfunction. The molecular environment shows elevated matrix metalloproteinases (MMPs), decreased tissue inhibitors of MMPs (TIMPs), growth factor degradation, and persistent inflammatory mediators.

Extracellular Matrix Alterations

The ECM in chronic wounds shows disorganized collagen structure, excessive fibronectin degradation, altered proteoglycan composition, and impaired basement membrane reformation. These changes create a hostile environment that perpetuates the non-healing state.

Biofilm Pathophysiology

Common organisms including Staphylococcus aureus, Pseudomonas aeruginosa, and Streptococcus spp. form biofilms through a process of bacterial adhesion, extracellular polymeric substance (EPS) production, mature biofilm architecture development, and dispersal cycles. Biofilms trap neutrophils in the matrix, reduce antimicrobial penetration, stimulate chronic inflammation, and impair growth factor signaling.

Therapeutic Targets

MMP Inhibition: Agents like doxycycline and synthetic MMP inhibitors restore protease-antiprotease balance.

Growth Factor Supplementation: PDGF (becaplermin), EGF, and FGF can overcome growth factor degradation in chronic wounds.

Cellular Therapies: Mesenchymal stem cells, keratinocyte sheets, and fibroblast therapy replace dysfunctional resident cells and provide fresh growth factor sources.